Purchase Order HHSN272201100183P
Award Date 12/29/10
Potential Completion Date 1/31/11
Potential Value $52K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, with a ceiling value of $51,975.00, was awarded to Qiagen Redwood City, Inc. on December 6, 2011. The contract is for a 1-year unlimited concurrent license for an information product called "LAW1573598 IPA GOVERNMENT CONCURRENT LICENSE" and is a firm fixed-price purchase order. The contract does not have...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for IPA software licenses. The contract is a firm fixed-price agreement with a potential value of $108,948.00 and a period of performance from February 1, 2018 to January 31, 2019. No set-aside designation was used. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies that has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen Redwood City, Inc. for a 1-year IPA (Intellectual Property Agreement) concurrent license starting on February 1, 2013. The contract has a firm fixed price of $69,300.00 and was awarded on December 5, 2012, with an ultimate completion date of December 28, 2012. The contract was not set aside for any specific business type. Qiagen Redwood City, Inc. is a for-profit organization...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen Redwood City, Inc., a subsidiary of the multinational biotechnology company Qiagen N.V. The contract provides for the renewal of an Ingenuity Pathways Analysis (IPA) software license for the period of February 1, 2014 to January 31, 2015, at a ceiling value of $79,800.00. The contract does not have a...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC. The contract is for 4 annual licenses of Qiagen's IPA (Ingenuity Pathway Analysis) advanced analytics software, with a total ceiling value of $99,750.00. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies, and has...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Qiagen Redwood City, Inc. The contract, valued at $83,840.90, is for the provision of Ingenuity Pathways Analysis Application software for the period of February 1, 2015 to January 31, 2016. The contract did not have a set-aside designation. Qiagen Redwood City, Inc. is a subsidiary of the parent...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC for the renewal of IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $92,225.00 and a period of performance ending on January 31, 2017. Qiagen, LLC is a division of the multinational biotechnology company Qiagen N.V., which provides a wide range of products and services to...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...
- This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The $126,230.40 contract is for IPA (Ingenuity Pathway Analysis) analysis services, with a completion date of January 31, 2020. Qiagen has previously provided a range of goods and services, including DNA/RNA extraction kits,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $17,090.82 firm fixed-price contract was awarded to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is a Blanket Purchase Agreement (BPA) call, indicating it is part of a larger indefinite delivery vehicle. Qiagen, LLC is...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a Firm Fixed Price purchase order contract to Qiagen Redwood City, Inc. on December 29, 2010. The contract, valued at $51,975.00, is for a one-year unlimited concurrent license for IPA-GCL software. The contract does not have a set-aside designation. The award was made directly to the vendor and is not associated with a larger contract vehicle.
Generated 11/24/24, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.0k | 12/29/10 |